Yong-ke You
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The renal histopathology of nonproteinuric kidney impairment: a three center experience.
Journal: Clinical and experimental medicine
Published: September 16, 2024
C-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 25, 2024
Roles and crosstalks of macrophages in diabetic nephropathy.
Journal: Frontiers in immunology
Published: August 09, 2022
Deletion of Smad3 protects against C-reactive protein-induced renal fibrosis and inflammation in obstructive nephropathy.
Journal: International journal of biological sciences
Published: May 19, 2021
Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
Journal: Metabolism: clinical and experimental
Published: August 01, 2019
Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling.
Journal: Journal of cellular and molecular medicine
Published: February 13, 2019
TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 22, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026